Loading clinical trials...
Loading clinical trials...
This is an open-label, non-randomized, Phase I, dose escalation/dose expansion study in cohorts of patients with relapsed, resistant, or metastatic HPV-associated cancers. The Expansion Phase will beg...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Toragen, Inc.
NCT07578467 · HPV Positive Oropharyngeal Squamous Cell Carcinoma, Squamous Cell Carcinoma, and more
NCT07576842 · Human Papillomavirus (HPV), HPV Associated Cancers, and more
NCT07090174 · HPV Associated Cancers, HIV (Human Immunodeficiency Virus), and more
City of Hope
Duarte, California
UCSD Moores Cancer Center
La Jolla, California
Yale University
New Haven, Connecticut
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions